Search research articles
Contact Us
Filters
Showing results (121-130 of 142) with videos related to
Page
of 15
Sort By:
International Journal of Gynecological Cancer : Official Journal of the International Gynecological Cancer Society
|
May 10, 2006
Genome-wide analysis of deoxyribonucleic acid in endometrial cancer using comparative genomic hybridization microarrays
S A O'Toole, E Dunn, B L Sheppard, et al.
Molecular and Cellular Endocrinology
|
March 25, 1996
CAG-repeat expansion in androgen receptor in Kennedy's disease is not a loss of function mutation
F Neuschmid-Kaspar, A Gast, H Peterziel, et al.
Cancer Detection and Prevention
|
January 1, 1996
Activation of two mutant androgen receptors from human prostatic carcinoma by adrenal androgens and metabolic derivatives of testosterone
Z Culig, J Stober, A Gast, et al.
European Urology
|
May 15, 1999
Mechanism of androgen receptor activation and possible implications for chemoprevention trials
H Klocker, Z Culig, I E Eder, et al.
The American Journal of Pathology
|
December 14, 1999
Basic fibroblast growth factor synthesis by human peritoneal mesothelial cells: induction by interleukin-1
M V Cronauer, S Stadlmann, H Klocker, et al.
World Journal of Urology
|
December 17, 2010
Long-term biochemical evaluation of the androgen receptor pathway in males with disorders of sex development
C Schwentner, J Czyz, J Seibold, et al.
The Prostate
|
February 1, 1997
Human prostatic smooth muscle cells in culture: estradiol enhances expression of smooth muscle cell-specific markers
J Zhang, M W Hess, M Thurnher, et al.
Urologia Internationalis
|
January 1, 1997
Dendritic cells for the immunotherapy of renal cell carcinoma
M Thurnher, H Klocker, C Papesh, et al.
Urologia Internationalis
|
January 1, 1995
Androgen receptor alterations in patients with disturbances in male sexual development and in prostatic carcinoma
H Klocker, F Neuschmid-Kaspar, Z Culig, et al.
British Journal of Cancer
|
September 25, 1999
Switch from antagonist to agonist of the androgen receptor bicalutamide is associated with prostate tumour progression in a new model system
Z Culig, J Hoffmann, M Erdel, et al.
Page
of 15
Search research articles
Search
Showing results (121-130 of 142) with videos related to
Sort By:
Page
of 15
International Journal of Gynecological Cancer : Official Journal of the International Gynecological Cancer Society
|
May 10, 2006
Genome-wide analysis of deoxyribonucleic acid in endometrial cancer using comparative genomic hybridization microarrays
S A O'Toole, E Dunn, B L Sheppard, et al.
Molecular and Cellular Endocrinology
|
March 25, 1996
CAG-repeat expansion in androgen receptor in Kennedy's disease is not a loss of function mutation
F Neuschmid-Kaspar, A Gast, H Peterziel, et al.
Cancer Detection and Prevention
|
January 1, 1996
Activation of two mutant androgen receptors from human prostatic carcinoma by adrenal androgens and metabolic derivatives of testosterone
Z Culig, J Stober, A Gast, et al.
European Urology
|
May 15, 1999
Mechanism of androgen receptor activation and possible implications for chemoprevention trials
H Klocker, Z Culig, I E Eder, et al.
The American Journal of Pathology
|
December 14, 1999
Basic fibroblast growth factor synthesis by human peritoneal mesothelial cells: induction by interleukin-1
M V Cronauer, S Stadlmann, H Klocker, et al.
World Journal of Urology
|
December 17, 2010
Long-term biochemical evaluation of the androgen receptor pathway in males with disorders of sex development
C Schwentner, J Czyz, J Seibold, et al.
The Prostate
|
February 1, 1997
Human prostatic smooth muscle cells in culture: estradiol enhances expression of smooth muscle cell-specific markers
J Zhang, M W Hess, M Thurnher, et al.
Urologia Internationalis
|
January 1, 1997
Dendritic cells for the immunotherapy of renal cell carcinoma
M Thurnher, H Klocker, C Papesh, et al.
Urologia Internationalis
|
January 1, 1995
Androgen receptor alterations in patients with disturbances in male sexual development and in prostatic carcinoma
H Klocker, F Neuschmid-Kaspar, Z Culig, et al.
British Journal of Cancer
|
September 25, 1999
Switch from antagonist to agonist of the androgen receptor bicalutamide is associated with prostate tumour progression in a new model system
Z Culig, J Hoffmann, M Erdel, et al.
Page
of 15